1. Home
  2. CCLD vs MXCT Comparison

CCLD vs MXCT Comparison

Compare CCLD & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareCloud Inc.

CCLD

CareCloud Inc.

HOLD

Current Price

$2.38

Market Cap

114.0M

Sector

Technology

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$0.84

Market Cap

93.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCLD
MXCT
Founded
1999
1999
Country
United States
United States
Employees
3650
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
93.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CCLD
MXCT
Price
$2.38
$0.84
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
596.1K
586.1K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$33,026,000.00
Revenue This Year
$11.49
N/A
Revenue Next Year
$7.95
$18.50
P/E Ratio
$32.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.95
$0.64
52 Week High
$4.01
$2.40

Technical Indicators

Market Signals
Indicator
CCLD
MXCT
Relative Strength Index (RSI) 31.45 51.68
Support Level $2.22 $0.77
Resistance Level $3.14 $0.89
Average True Range (ATR) 0.17 0.05
MACD -0.07 -0.00
Stochastic Oscillator 11.16 51.87

Price Performance

Historical Comparison
CCLD
MXCT

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: